Carbonic anhydrase inhibitors: Binding of an antiglaucoma glycosyl-sulfanilamide derivative to human isoform II and its consequences for the drug design of enzyme inhibitors incorporating sugar moieties
Authors:
- Andrea ScozzafavaASAndrea Scozzafava
- Jean-Yves WinumJWJean-Yves Winum
- Jean-Louis MonteroJMJean-Louis Montero
- Carlo PedoneCPCarlo Pedone
- Claudiu T. SupuranClaudiu T. Supuran
- Giuseppina De SimoneGiuseppina De Simone
- 1 March 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (6) , 1726-1731
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Carbonic anhydrase inhibitors and activators and their use in therapyExpert Opinion on Therapeutic Patents, 2006
- Targeting tumor-associated carbonic anhydrase IX in cancer therapyTrends in Pharmacological Sciences, 2006
- New Zinc Binding Motifs in the Design of Selective Carbonic Anhydrase InhibitorsMini-Reviews in Medicinal Chemistry, 2006
- Carbonic Anhydrase Inhibitors: X-ray and Molecular Modeling Study for the Interaction of a Fluorescent Antitumor Sulfonamide with Isozyme II and IXJournal of the American Chemical Society, 2006
- Therapeutic potential of sulfamides as enzyme inhibitorsMedicinal Research Reviews, 2006
- The sulfamide motif in the design of enzyme inhibitorsExpert Opinion on Therapeutic Patents, 2005
- Sulfamates and their therapeutic potentialMedicinal Research Reviews, 2004
- Modulation of carbonic anhydrase activity and its applications in therapyExpert Opinion on Therapeutic Patents, 2004
- Review ArticleJournal of Enzyme Inhibition and Medicinal Chemistry, 2004
- Carbonic anhydrase inhibitorsMedicinal Research Reviews, 2002